Elevance Health Long Term Debt 2010-2025 | ELV
Elevance Health long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Elevance Health long term debt for the quarter ending March 31, 2025 was $28.110B, a 27.91% increase year-over-year.
- Elevance Health long term debt for 2024 was $29.218B, a 25.69% increase from 2023.
- Elevance Health long term debt for 2023 was $23.246B, a 4.01% increase from 2022.
- Elevance Health long term debt for 2022 was $22.349B, a 5.63% increase from 2021.
| Elevance Health Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $29,218 |
| 2023 | $23,246 |
| 2022 | $22,349 |
| 2021 | $21,157 |
| 2020 | $19,335 |
| 2019 | $17,787 |
| 2018 | $17,217 |
| 2017 | $17,382 |
| 2016 | $14,359 |
| 2015 | $15,325 |
| 2014 | $14,020 |
| 2013 | $13,574 |
| 2012 | $14,171 |
| 2011 | $8,466 |
| 2010 | $8,148 |
| 2009 | $8,338 |
| Elevance Health Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $28,110 |
| 2024-12-31 | $29,218 |
| 2024-09-30 | $24,688 |
| 2024-06-30 | $24,561 |
| 2024-03-31 | $21,976 |
| 2023-12-31 | $23,246 |
| 2023-09-30 | $24,045 |
| 2023-06-30 | $24,859 |
| 2023-03-31 | $25,201 |
| 2022-12-31 | $22,349 |
| 2022-09-30 | $21,258 |
| 2022-06-30 | $21,165 |
| 2022-03-31 | $19,883 |
| 2021-12-31 | $21,157 |
| 2021-09-30 | $21,761 |
| 2021-06-30 | $22,217 |
| 2021-03-31 | $22,534 |
| 2020-12-31 | $19,335 |
| 2020-09-30 | $19,094 |
| 2020-06-30 | $19,873 |
| 2020-03-31 | $19,005 |
| 2019-12-31 | $17,787 |
| 2019-09-30 | $18,820 |
| 2019-06-30 | $17,436 |
| 2019-03-31 | $17,396 |
| 2018-12-31 | $17,217 |
| 2018-09-30 | $17,300 |
| 2018-06-30 | $17,515 |
| 2018-03-31 | $18,110 |
| 2017-12-31 | $17,382 |
| 2017-09-30 | $13,777 |
| 2017-06-30 | $15,088 |
| 2017-03-31 | $15,450 |
| 2016-12-31 | $14,359 |
| 2016-09-30 | $14,242 |
| 2016-06-30 | $14,202 |
| 2016-03-31 | $14,865 |
| 2015-12-31 | $15,325 |
| 2015-09-30 | $15,720 |
| 2015-06-30 | $15,468 |
| 2015-03-31 | $14,764 |
| 2014-12-31 | $14,020 |
| 2014-09-30 | $14,538 |
| 2014-06-30 | $14,038 |
| 2014-03-31 | $13,932 |
| 2013-12-31 | $13,574 |
| 2013-09-30 | $14,514 |
| 2013-06-30 | $14,092 |
| 2013-03-31 | $14,030 |
| 2012-12-31 | $14,171 |
| 2012-09-30 | $13,396 |
| 2012-06-30 | $10,136 |
| 2012-03-31 | $8,463 |
| 2011-12-31 | $8,466 |
| 2011-09-30 | $8,622 |
| 2011-06-30 | $8,292 |
| 2011-03-31 | $8,542 |
| 2010-12-31 | $8,148 |
| 2010-09-30 | $8,217 |
| 2010-06-30 | $7,335 |
| 2010-03-31 | $7,630 |
| 2009-12-31 | $8,338 |
| 2009-09-30 | $8,384 |
| 2009-06-30 | $8,514 |
| 2009-03-31 | $8,527 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $94.145B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.728B | 26.96 |
| CVS Health (CVS) | United States | $81.986B | 10.19 |
| Cencora (COR) | United States | $53.983B | 18.77 |
| Natera (NTRA) | United States | $21.477B | 0.00 |
| DiDi Global (DIDIY) | China | $21.462B | 32.57 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.941B | 13.70 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
| Revvity (RVTY) | United States | $11.610B | 19.98 |
| Doximity (DOCS) | United States | $11.396B | 59.26 |
| ICON (ICLR) | Ireland | $11.324B | 10.53 |
| CochLear (CHEOY) | Australia | $11.195B | 0.00 |
| Viatris (VTRS) | United States | $10.516B | 3.61 |
| Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
| Avantor (AVTR) | United States | $8.859B | 12.87 |
| HealthEquity (HQY) | United States | $8.361B | 41.13 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
| BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
| Sotera Health (SHC) | United States | $3.832B | 21.77 |
| Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
| Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 16.01 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
| Premier (PINC) | United States | $2.101B | 14.38 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
| GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
| Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
| Agilon Health (AGL) | United States | $1.229B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.911B | 14.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
| Embecta (EMBC) | United States | $0.725B | 4.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.689B | 13.50 |
| Enhabit (EHAB) | United States | $0.530B | 43.58 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
| Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.389B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| SBC Medicals (SBC) | United States | $0.359B | 0.00 |
| Beauty Health (SKIN) | United States | $0.220B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.08 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |